呼吸道淋巴细胞和先天性免疫细胞的发育性免疫网络在稳定的COPD患者中
Lanlan Liu1, Mei Zhou1, Shengwen Sun2
1Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, Key Laboratory of Pulmonary Diseases of National Health Commission, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in immunology
|July 1, 2025
概括
这项研究揭示了慢性阻塞性肺病 (COPD) 气道中的免疫细胞失调. 关键发现包括耗尽的T细胞,改变的调节性T细胞和重编程的巨细胞,为COPD免疫平衡提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 单细胞转录组学 单细胞转录组学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及持续的呼吸道炎症和免疫功能障碍.
- 对于COPD呼吸道中免疫细胞的特定分子变化和起源还不太清楚.
研究的目的:
- 创建一个完整的COPD气道免疫细胞单细胞转录基因地图.
- 识别导致COPD免疫功能障碍的分子变化和细胞起源.
主要方法:
- 从支气管洗液和外围血液单核细胞中收集的CD45+免疫细胞.
- 通过单细胞转录学分析了四名COPD患者和四名健康吸烟者的样本.
主要成果:
- CD8+ T细胞显示疲劳增加,细胞毒性降低,TCR多样性降低.
- 调节性T细胞的比例和容量减少;CD4+T细胞表现出偏斜的Th2/Th1反应.
- 单细胞衍生的巨细胞 (Macro_SPP1) 显示了脂质重编程,抗炎转移,减少了细胞分裂,以及改变了蛋白酶-抗蛋白酶平衡.
- 巨细胞通过SPP1和GALECTIN信号与T细胞相互作用,可能抑制T细胞功能.
结论:
- 在COPD呼吸道中的解脱失调的免疫反应.
- 确定了特定的免疫细胞变化,包括耗尽的T细胞和重新编程的巨细胞.
- 提供了一种资源,用于识别治疗点,以恢复COPD中的免疫平衡.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20COPD: Pathogenesis and Clinical Features
535
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:17Drugs Used in Lower Respiratory Disorders: Overview
618
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
618
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K